NCT06468098
- Conditions
- Advanced Malignancies
- Locations
-
- Shanghai Chest Hospita Shanghai, Shanghai Municipality, China
Clinical trial condition
Advanced Malignancies
Explore clinical trials studying Advanced Malignancies. Study availability and eligibility vary by location and protocol.
59 public trials
12 recruiting studies
Advanced Malignancies trial results
NCT06202261
- Conditions
- Advanced Malignancies, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Affiliated Cancer Hospital of Chongqing University Chongqing, Chongqing Municipality, China
- Affiliated cancer hospital of harbin medical university Harbin, Heilongjiang, China
Not yet recruiting
Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies
NCT07504263
- Conditions
- Advanced Malignancies, Cancer, Colonic Diseases, +17 more
- Locations
-
Not specified
Not yet recruiting
Phase I Study of XZ120 in Malignant Tumors
NCT06206915
- Conditions
- Advanced Malignancies
- Locations
-
Not specified
Active, not recruiting
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
NCT05891171
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
- Locations
-
- Research Site Phoenix, Arizona, United States
- Research Site Jacksonville, Florida, United States
- Research Site Lake City, Florida, United States
- Research Site Hinsdale, Illinois, United States
Active, not recruiting
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
NCT05059522
- Conditions
- Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +17 more
- Locations
-
- Highlands Oncology Group, PA Fayetteville, Arkansas, United States
- Highlands Oncology Group, PA Rogers, Arkansas, United States
- Highlands Oncology Group, PA Springdale, Arkansas, United States
- The Regents of the University of California Los Angeles, California, United States
Active, not recruiting
Safety and Pharmacokinetics of Cemiplimab Anti-programmed Death-ligand 1 (Anti-PD-1) and Other Agents in Japanese Adult Patients With Advanced Malignancies
NCT03233139
- Conditions
- Advanced Malignancies
- Locations
-
- National Hospital Organization Nagoya Medical Center Nagoya, Aichi-ken, Japan
- Kurume University Hospital Kurume, Fukuoka, Japan
- Gunma Prefectural Cancer Center Ōta, Gunma, Japan
- Kobe City Medical Center General Hospital Kobe, Hyōgo, Japan
NCT04181788
- Conditions
- Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
- Locations
-
- Beijing Cancer hospital Beijing, Beijing Municipality, China
- Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
- Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
- Huashan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China
NCT04164199
- Conditions
- Advanced Malignancies
- Locations
-
- Mount Sinai Medical Center Braman Comprehensive Cancer Center Miami, Florida, United States
- Memorial Sloan Kettering Cancer Center Mskcc New York, United States
- Tennessee Oncology, Pllc Nashville Nashville, Tennessee, United States
- Baylor Research Institute Dallas, Texas, United States
NCT05577182
- Conditions
- Advanced Malignancies, Carcinoma, Carcinoma, Squamous Cell, +15 more
- Locations
-
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- University of Texas Md Anderson Cancer Center Houston, Texas, United States
- Cliniques Universitaires Ucl Saint-Luc Brussels, Belgium
- Universitair Ziekenhuis Antwerpen (Uza) Edegem, Belgium